Should Biotechnology Stock Verve Therapeutics Inc (VERV) Be in Your Portfolio Friday?

Verve Therapeutics Inc (VERV) is around the middle of the Biotechnology industry according to InvestorsObserver. VERV received an overall rating of 41, which means that it scores higher than 41 percent of all stocks. Verve Therapeutics Inc also achieved a score of 44 in the Biotechnology industry, putting it above 44 percent of Biotechnology stocks. Biotechnology is ranked 49 out of the 148 industries.

VERV has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on VERV!

See Full VERV Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 41 would rank higher than 41 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Verve Therapeutics Inc Stock Today?

Verve Therapeutics Inc (VERV) stock is trading at $12.41 as of 10:42 AM on Friday, Nov 24, a gain of $0.37, or 3.07% from the previous closing price of $12.04. The stock has traded between $12.09 and $12.58 so far today. Volume today is light. So far 134,473 shares have traded compared to average volume of 2,150,492 shares. Click Here to get the full Stock Report for Verve Therapeutics Inc stock.